Sale of Shares

Insight Foundation Property Tst Ltd
19 January 2006


NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES,
CANADA, AUSTRALIA OR JAPAN.

Insight Foundation Property Trust Limited

19 January 2006

SALE OF SHARES

JPMorgan Cazenove Limited ('JPMorgan Cazenove') announces an offering on behalf
of Clerical Medical Investment Group Limited ('CMIG') of up to 35,000,000
ordinary shares at 115p per share ('Offering Shares') in Insight Foundation
Property Trust Limited ('IFPT') representing approximately 10 per cent of IFPT's
issued share capital, as described below (the 'Offering').

The Offering Shares are being offered by way of an institutional bookbuilding.
JPMorgan Cazenove is acting as sole bookrunner and lead manager to the Offering.

The Offering is expected to close on or before the close of business on 19
January 2006.  The exact number of Offering Shares to be sold in the Offering
will be announced thereafter.  JPMorgan Cazenove reserves the right to close the
book at any earlier time.  Settlement is expected to be on 24 January 2006.
Investors wishing to participate should contact the sales desk at  JPMorgan
Cazenove.

The sale reflects a desire to reduce the proportion of CMIG's portfolio that is
invested in a single investment company. CMIG has been, and continues to be,
satisfied with the strategy and performance of IFPT and the balance of the
investment in IFPT remains an important part of CMIG's portfolio. CMIG has
confirmed it has no intention of further reducing its shareholding before 30
June 2006.

Enquiries:

Duncan Owen       (Insight Investment Management)              0207 321 1677

Richard Cotton (JPMorgan Cazenove)                             020 7588 2828

Angus Gordon Lennox (JPMorgan Cazenove)                        020 7588 2828

This announcement is issued on behalf of the CMIG by JPMorgan Cazenove who are
regulated by the Financial Services Authority and does not constitute any offer
to sell or any solicitation of any offer to purchase any securities.  JPMorgan
Cazenove are acting for CMIG in connection with the sale and for no one else and
will not be responsible to anyone other than CMIG for providing the protections
offered to prospective customers of JPMorgan Cazenove nor for providing advice
in relation to the sale.


Neither this document nor any copy of it may be transmitted into the United
States of America, its territories and possessions, any state of the United
States or the District of Columbia (the 'United States') or distributed,
directly or indirectly to any US person as defined in Regulation S under the
Securities Act, as amended.  Any failure to comply with this restriction may
constitute a violation of US securities laws.  The Offering Shares are not being
registered under the Securities Act and may not be offered or sold in the United
States or to or for the account of any US person unless registered under the
Securities Act or pursuant to an exemption from such registration.  No public
offer is being made in the United States.


Neither this document nor any copy of it may be distributed in Canada, Australia
or in Japan or to any resident thereof or in any other jurisdiction where such
distribution would be unlawful under the laws of such jurisdiction.

END


                      This information is provided by RNS
            The company news service from the London Stock Exchange